These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2433727)

  • 61. In vitro resistance to interferon of hepatitis B virus with precore mutation.
    Wang Y; Wei L; Jiang D; Cong X; Fei R; Xiao J; Wang Y
    World J Gastroenterol; 2005 Feb; 11(5):649-55. PubMed ID: 15655815
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumorigenicity and interferon properties of the PLC/PRF/5 human hepatoma cell line.
    Desmyter J; De Groote G; Ray MB; Bradburne AF; Desmet V; De Somer P; Alexander J
    Prog Med Virol; 1981; 27():103-8. PubMed ID: 6165050
    [No Abstract]   [Full Text] [Related]  

  • 63. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
    Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease.
    Chemin I; Jeantet D; Kay A; Trépo C
    Antiviral Res; 2001 Nov; 52(2):117-23. PubMed ID: 11672821
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc.
    Oon CJ; Chen WN; Goh KT; Mesenas S; Ng HS; Chiang G; Tan C; Koh S; Teng SW; Toh I; Moh MC; Goo KS; Tan K; Leong AL; Tan GS
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S491-6. PubMed ID: 12534784
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
    Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
    Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
    [TBL] [Abstract][Full Text] [Related]  

  • 67. State of hepatitis B viral DNA in the liver of patients with hepatocellular carcinoma and chronic liver disease.
    Hada H; Arima T; Togawa K; Okada Y; Morichika S; Nagashima H
    Liver; 1986 Aug; 6(4):189-98. PubMed ID: 3022098
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modulation of hepatitis B surface antigen secretion by annexin II expressed in hepatitis B virus‑producing hepatoma cells.
    Liu Y; Gao P
    Mol Med Rep; 2014 Dec; 10(6):3113-7. PubMed ID: 25270731
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver.
    Hsia CC; Axiotis CA; Di Bisceglie AM; Tabor E
    Cancer; 1992 Sep; 70(5):1049-56. PubMed ID: 1325266
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Presence of receptors for polymerized albumin in HBsAg-containing hepatocytes and hepatoma cell line.
    Thung SN; Gerber MA
    Hepatology; 1981; 1(2):132-6. PubMed ID: 6269978
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatitis B viral DNA in infected human liver and in hepatocellular carcinoma.
    Miller RH; Lee SC; Liaw YF; Robinson WS
    J Infect Dis; 1985 Jun; 151(6):1081-92. PubMed ID: 2987366
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modulation of production of hepatitis B surface antigen by a human hepatoma cell line.
    Clementi M; Bagnarelli P; Pauri P; Calegari L
    J Med Virol; 1984; 13(2):117-23. PubMed ID: 6198456
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes.
    Wu JF; Hsu HY; Ni YH; Chen HL; Wu TC; Chang MH
    Am J Pathol; 2012 Jul; 181(1):19-25. PubMed ID: 22634051
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.
    Saitta C; Tripodi G; Barbera A; Bertuccio A; Smedile A; Ciancio A; Raffa G; Sangiovanni A; Navarra G; Raimondo G; Pollicino T
    Liver Int; 2015 Oct; 35(10):2311-7. PubMed ID: 25677098
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells.
    Chen HC; Chou CK; Sun CM; Yeh SF
    Antiviral Res; 1997 May; 34(3):137-44. PubMed ID: 9191021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.
    Lau JY; Bird GL; Naoumov NV; Williams R
    Dig Dis Sci; 1993 May; 38(5):888-95. PubMed ID: 7683263
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evidence for non-chromosomal hepatitis B virus surface (HBsAg)- and core antigen (HBcAg)-specific DNA sequences in a hepatoma cell line.
    Marquardt O; Zaslavsky V; Hofschneider PH
    J Gen Virol; 1982 Jul; 61 (Pt l)():105-9. PubMed ID: 6288845
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma.
    Nair PV; Tong MJ; Kempf R; Co R; Lee SD; Venturi CL
    Cancer; 1985 Sep; 56(5):1018-22. PubMed ID: 2990662
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
    J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.